Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRoyalty Pharma plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | $0.86 | $1.39 | $1.07 |
| Q2 2025 | 2 | $0.85 | $1.14 | $1.00 |
| Q3 2025 | 2 | $1.12 | $1.50 | $1.31 |
| Q4 2025 | 2 | $1.13 | $1.51 | $1.32 |
Royalty Pharma plc Earnings Date And Information
Royalty Pharma plc last posted its earnings results on Tuesday, February 11th, 2025. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.99 by $0.16. The company had revenue of 594.00 M for the quarter and had revenue of 2.26 B for the year. Royalty Pharma plc has generated $2 earnings per share over the last year ($1.45 diluted earnings per share) and currently has a price-to-earnings ratio of 17.12. Royalty Pharma plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Royalty Pharma plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/11/2025 | Q4 2024 | $0.99 | $0.46 | -0.53 | $687.10 M | $594.00 M |
| 11/06/2024 | Q3 2024 | $0.93 | $1.61 | 0.68 | $696.92 M | $564.69 M |
| 08/08/2024 | Q2 2024 | $0.97 | $0.23 | -0.74 | $627.42 M | $537.27 M |
| 05/09/2024 | Q1 2024 | $0.99 | $0.01 | -0.98 | $665.57 M | $567.98 M |
| 02/15/2024 | Q4 2023 | $1.01 | $1.11 | 0.1 | $685.52 M | $596.00 M |
| 11/08/2023 | Q3 2023 | $0.81 | $0.16 | -0.65 | $631.74 M | $536.31 M |
| 08/08/2023 | Q2 2023 | $0.83 | $0.51 | -0.32 | $543.70 M | $538.20 M |
| 05/09/2023 | Q1 2023 | $1.32 | $0.76 | -0.56 | $902.02 M | $683.97 M |
| 02/15/2023 | Q4 2022 | $1.56 | -$1.38 | -2.94 | N/A | $565.75 M |
| 11/08/2022 | Q3 2022 | $0.71 | $0.36 | -0.35 | $586.32 M | $573.46 M |
| 08/04/2022 | Q2 2022 | $0.78 | $0.50 | -0.28 | $528.36 M | $535.96 M |
| 05/05/2022 | Q1 2022 | $0.72 | -$0.07 | -0.79 | N/A | $562.05 M |
| 02/15/2022 | Q4 2021 | $0.79 | $0.02 | -0.77 | N/A | $575.70 M |
| 11/10/2021 | Q3 2021 | $0.69 | $0.24 | -0.45 | $563.10 M | $585.77 M |
| 08/11/2021 | Q2 2021 | $0.70 | $1.08 | 0.38 | $484.33 M | $554.96 M |
| 05/11/2021 | Q1 2021 | $0.65 | $0.18 | -0.47 | N/A | $573.03 M |
| 02/24/2021 | Q4 2020 | N/A | $0.44 | N/A | N/A | $571.00 M |
| 11/12/2020 | Q3 2020 | N/A | $0.79 | N/A | $451.66 M | $539.00 M |
| 08/12/2020 | Q2 2020 | $0.61 | $1.25 | 0.64 | $468.93 M | $510.93 M |
| 03/30/2020 | Q1 2020 | N/A | $0.20 | N/A | N/A | $500.88 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Royalty Pharma plc Earnings: FAQ's
Royalty Pharma plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based offlast year's report dates.
In the previous quarter, Royalty Pharma plc (:RPRX) reported $1.15 earnings per share (EPS) to beat the analysts' consensus estimate of $0.99 by $0.16.
The conference call for Royalty Pharma plc's latest earnings report can be listened to online.
The conference call transcript for Royalty Pharma plc's latest earnings report can be read online.
Royalty Pharma plc (:RPRX) has a recorded annual revenue of $2.26 B.
Royalty Pharma plc (:RPRX) has a recorded net income of $859.00 M.Royalty Pharma plc has generated $1.92 earnings per share over the last four quarters.
Royalty Pharma plc (:RPRX) has a price-to-earnings ratio of 17.12 and price/earnings-to-growth ratio is -0.78.